Mechanical Aspiration in ST Elevation ACS

In ST elevation ACS the preferred treatment is primary PCI. However, one its limitations is thrombus presence and its distal embolization, which threatens microcirculation perfusion and is therefore associated to ventricular function deterioration and bad evolution.

Aspiración mecánica en el IAM con supradesnivel del ST

Manual thrombus aspiration has been tested in different studies but the problem remains unsolved; mechanical thrombectomy might be a solution to this complication, so difficult to handle. 

The CHEETAH study (prospective, multicenter) included 400 patients with ST-ACS presenting within 12 hrs. of symptom onset treated with mechanical thrombectomy with CAT RX Aspiration System (Penumbra Inc, Alameda CA). 

Primary end point was a composite of cardiovascular death, repeat MI, cardiogenic shock or new class IV cardiac failure at 30 days.

Mean age was 60, most patients were men, 25% were diabetic, 2% had prior CABG and 20% prior PCI.

Most patients were in Killip class I-II. Compromised arteries were the right coronary, in half of patients, followed by the anterior descending and, less frequently, the circumflex. 

Read also: ACC 2023 | Subanalysis of the REVIVED-BICS Study2.

 Final rates of TIMI 0 was 99.50%, TIMI flow 3, 97.50% and myocardial blush grade 3 was 99.75%, with no device complications. 

Primary end point occurred in 3.6% of cases (95% CI, 2.0–6.0%) compared against the historical rate of 6.1%  (Pnoninferiority <0.001).

At 30 days, cardiovascular mortality was 0.51%, stroke 0.77%, major bleeding 1%.

Conclusion

Mechanical aspiration before PCI in acute coronary syndrome with high thrombus burden was safe, and was associated to high thrombus removal with flow restauration and normal perfusion on final angiography. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board ofSOLACI.org.

Original Title: Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study.

Reference: S. Jay Mathews, et al. Circ Cardiovasc Interv. 2023;16:e012433. DOI: 10.1161/CIRCINTERVENTIONS.122.012433. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...